Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Processa Pharmaceuticals, Inc. (PCSA)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | | | | | | | 0.0 | 0.3 |
| Asset turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -943.9% | | | | | -620.6% | 0.0% | -263.8% |
| ROIC (including intangibles) | -112.6% | -63.6% | -36.9% | -35.8% | 77.6% | -153.9% | 0.0% | -253.5% |
| ROE | -43.4% | -26.2% | -41.6% | -37.6% | -483.0% | -84.8% | 0.0% | -373.2% |
| ROA | -41.8% | -23.9% | -30.7% | -29.2% | -60.4% | -81.3% | 0.0% | -177.1% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | | | | | | 0.0 | | 4.5 |
| Days payables outstanding | | | | | | 2.8 | | 840.7 |
| Days inventory outstanding | | | | | | | | 1,197.1 |
| Cash conversion cycle | | | | | | -2.8 | | 360.9 |
|